Diabetes prevention while treating obesity: STEP by STEP analysis of an apparently inSURMOUNTable problem - Top-Institutions - MDSpire

Diabetes prevention while treating obesity: STEP by STEP analysis of an apparently inSURMOUNTable problem

  • By

  • Maria Chantal Ponziani

  • Marco Chianelli

  • On behalf of Obesity Commission of Associazione Medici Endocrinologi

  • January 20, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Harvard Medical School / Massachusetts General Hospital
    Harvard Medical School / Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Metabolism
    • Obesity Research
    • Diabetes Prevention

  • #2

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Obesity Medicine
    • Diabetes Research

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Obesity and Metabolic Disorders
    • Clinical Trials

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Diabetes Research
    • Obesity Treatment

  • #5

    University of Pennsylvania (Perelman School of Medicine)
    University of Pennsylvania (Perelman School of Medicine)

    Philadelphia, PA

    Key Differentiators

    • Endocrinology
    • Metabolic Disease Research
    • Obesity Pharmacotherapy

Original Source(s)

Diabetes prevention while treating obesity: STEP by STEP analysis of an apparently inSURMOUNTable problem

  • by Maria Chantal Ponziani, Marco Chianelli, On behalf of Obesity Commission of Associazione Medici Endocrinologi

  • January 20, 2026

Related Content

IPS Could Minimize GI Effects in Treating Iron Deficiency

Review summarizes pharmacokinetic and clinical data on iron protein succinylate across patients with iron deficiency and iron deficiency anemia.

Editorial: Cardiovascular risks in cardiovascular-kidney-metabolic syndrome: mechanisms and therapies

Grip Strength Plus Waist Size May Flag Risk T2D Risk

Researchers found that patients with higher waist circumference and lower grip strength had the greatest risk for developing type 2 diabetes during long-term follow-up.